MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Targeting TLR4 for disease modification in multiple system atrophy: Experimental evidence

    S. Venezia, V. Refolo, N. Stefanova (Innsbruck, Austria)

    Objective: To assess the efficacy of toll-like receptor 4(TLR4) agonists to ameliorate the functional and neuropathological phenotype of a transgenic mouse model of multiple system…
  • 2016 International Congress

    Progression of microglial activation and neuroinflammatory responses in a transgenic mouse model of multiple system atrophy

    V. Refolo, S. Venezia, G.K. Wenning, M. Romero-Ramos, N. Stefanova (Innsbruck, Austria)

    Objective: Our aim was to characterize the progression of microglial activation during disease progression in a transgenic mouse model of multiple system atrophy (MSA). Background:…
  • 2016 International Congress

    Deep brain stimulation may lead to dramatic worsening of slowly progressive multiple system atrophy: A clinico-pathological series and review of the literature

    C. Laurencin, W. Meissner, C. Tranchant, T. Witjas, F. Viallet, P. Damier, T. Danaila, J.L. Houeto, A. Eusebio, S. Thobois (Lyon, France)

    Objective: The aim of the present study is to describe one of the largest series of histologically proven multiple system atrophy (MSA) patients, who underwent…
  • 2016 International Congress

    Imaging correlates of hypodipsia in progressive supranuclear palsy

    G. Respondek, T. Conrad, I. Riederer, T. Reeß, G. Rus, K. Koch, G. Höglinger, C. Zimmer (Munich, Germany)

    Objective: Aims of the present study were• to confirm hypodipsia as a characteristic feature of PSP and• to offer hypothesis on the pathological substrate for…
  • 2016 International Congress

    The score changes of clinical symptom assessment scales for multiple system atrophy in 2-3 years

    M. Matsushima, I. Yabe, I. Takahashi, K. Sakushima, F. Nakano, M. Hirotani, T. Kano, K. Horiuchi, H. Houzen, H. Sasaki (Sapporo, Japan)

    Objective: To examine the extent of disease progression for multiple system atrophy (MSA) during relatively long duration. Background: The knowledge of MSA natural history is…
  • 2016 International Congress

    Heart rate variability and sympathetic skin response are useful in the evaluation of Parkinson’s disease, AMS, and Parkinson plus syndrome, but underutilized in daily clinical practice

    R.C. Callejas Rojas, B. Estañol Vidal (Mexico, Mexico)

    Objective: Assess the heart rate (HR) coefficient of variance (CV) in three conditions: supine, active standing and during deep breathing; and measure the sympathetic skin…
  • 2016 International Congress

    A longitudinal observational study of a cohort of patients with PSP/CBD: The JALPAC project

    T. Tokuda, T. Ikeuchi, H. Takigawa, I. Aiba, T. Shimohata, M. Morita, O. Onodera, S. Murayama, K. Nakashima (Kyoto, Japan)

    Objective: To identify PSP/CBD progression biomarkers both to improve understanding of disease etiology and course, and to provide crucial tools to enhance the likelihood of…
  • 2016 International Congress

    Could tonic chin electromyogram density be a potential marker for differentiating atypical Parkinsonian syndromes from Parkinson’s disease among alpha-synucleinopathies?

    Y. Wang, K.P. Xiong, Y. Shen, P.C. He, C.J. Mao, J. Li, J.Y. Huang, C.F. Liu (Suzhou, People's Republic of China)

    Objective: The study aimed to examine whether the video-polysomnography (vPSG) could provide some clues for differentiating atypical Parkinsonian syndromes (APS) from Parkinson's disease (PD) among…
  • 2016 International Congress

    Apraxia of speech as the initial manifestation of progressive supranuclear palsy

    J.J. Bravo, M.J. Gallardo, J.P. Cabello, R.E. Ibañez, J. Vaamonde (Ciudad Real, Spain)

    Objective: We report a patient with apraxia of speech as the initial symptom who finally developed a progressive supranuclear palsy. Background: Progressive supranuclear palsy (PSP)…
  • 2016 International Congress

    High frequency of mutations in the glucocerebrosidase (GBA) gene among Ashkenazi Jews with dementia with Lewy bodies

    T. Shiner, A. Mirelman, M. Gana Weisz, A. Bar-Shira, E. Ash, R. Cialic, T. Gurevich, N. Bregman, A. Orr-Urtreger, N. Giladi (Tel Aviv, Israel)

    Objective: The objective of this study was to characterize, clinically and genetically, anAshkenazi Jewish cohort of patients diagnosed with DLB, looking for the association with…
  • « Previous Page
  • 1
  • …
  • 1539
  • 1540
  • 1541
  • 1542
  • 1543
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley